Posted On: July 21, 2023
Stock Report : NEULANDLAB (NSE) 20 Jul 2023
Industry: Drug Manufacturers – Specialty & Generic
Neu land Laboratories Ltd. is an Indian pharmaceutical company that specializes in the manufacturing and development of active pharmaceutical ingredients (APIs) and intermediates. The company has a global presence and caters to various industries, including generic pharmaceuticals and biotechnology. Neu land is known for its commitment to quality and compliance with international regulatory standards. They strive to offer cost-effective solutions to their customers while maintaining a focus on research and innovation in the pharmaceutical sector.
xCalData predicts NEULANDLAB will continue its Bullish phase over the next five days and trend in the range of 3228 to 3399.
In comparison to the previous month, the price of the stock has experienced an increase of 9.83% indicating a Bullish.
Majority of the technical ratios trend towards Bullish side of the spectrum. Only ASI and RVI indicates bearish view.
Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days.
The Stock has doubled Thrice since 26 Feb 2015 and took an average of 2.1 years to double.
The stock has not shown seasonality trend in the past.
Reviewing the returns for the past 5 years for the same week, we see the stock has given Positive returns in 3 years in the past.
#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market. Download the app from google play.
For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData